Browsing by Author Applegate, Tanya

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2016Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDouglas, Mark; George, Jacob; Sheridan, David; Applegate, Tanya; Askew, Ben; Dore, Gregory J.; et al, .; Fenwick, Fiona; Hajarizadeh, Behzad; Matthews, Gail; Neely, Dermot; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResMaximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection, Liver International, vol.36, 12, 2016,pp 1774-1782
2016Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDouglas, Mark; George, Jacob; Sheridan, David; Applegate, Tanya; Askew, Ben; Dore, Gregory J.; et al, .; Fenwick, Fiona; Hajarizadeh, Behzad; Matthews, Gail; Neely, Dermot; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResMaximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection, Liver International, vol.36, 12, 2016,pp 1774-1782
2013Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infectionGeorge, Jacob; Applegate, Tanya; Bruneau, Julie; Cherepanov, Vera; Dore, Gregory; Feld, Jordan; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Matthews, Gail; Petoumenos, Kathy; Shaw, Ineke; Sherker, Alana; Shoukry, Naglaa H.; Teutsch, Suzy; Yeung, Barbara; Zang, Geng; Western Clinical School: Westmead Millennium InstitutePlasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection, Hepatology, vol.57, 6, 2013,pp 2124-2134
2010Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus InfectionBooth, David; George, Jacob; Suppiah, Vijayaprakash; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew R.; Marks, Phillipa; Matthews, Gail V; Petoumenos, Kathy; Rawlinson, William; Yeung, Barbara; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstitutePotential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection, Hepatology, vol.52, 4, 2010,pp 1216-1224
2017Sequencing of Hepatitis C Virus for Detection of Resistance to Direct-Acting Antiviral Therapy: A Systematic ReviewDouglas, Mark; Applegate, Tanya; Bartlett, Sofia; Bull, Rowena; Ceccherini-Silberstein, Francesca; Dore, Gregory; Eltahla, Auda A; Feld, Jordan; Garcia, Federico; Grebely, Jason; Harrington, Patrick; Howe, Anita; Jacka, Brendan; Lennerstrand, Johan; Lloyd, Andrew R.; Matthews, Gail V; Miller, Veronica; Pawlotsky, Jean Michel; Reeves, Jacqueline; Schinkel, Janke; Wang, Gary; Westmead Clinical School: Westmead Institute for Medical ResSequencing of Hepatitis C Virus for Detection of Resistance to Direct-Acting Antiviral Therapy: A Systematic Review, Hepatology Communications, vol.1, 5, 2017,pp 379-390
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434
2012Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infectionGeorge, Jacob; Applegate, Tanya; Dore, Gregory; Feld, Jordan; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Matthews, Gail V; Petoumenos, Kathy; Rawlinson, William; Yeung, Barbara; Western Clinical School: Westmead Millennium InstituteVirological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection, AIDS, vol.26, 13, 2012,pp 1653-1661